Cargando…

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2

Coronavirus Disease 2019 (COVID-19) is a highly infectious and pathogenic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Early in this epidemic, the herbal formulas used in traditional Chinese medicine (TCM) were widely used for the treatment of COVID-19 in China...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Ming-Feng, Liang, Jian-Hui, Shen, Yan-Ni, Zhang, Jin-Wen, Liu, Ying, Yang, Kuang-Yang, Liu, Li-Chu, Wang, Junyi, Xie, Qian, Hu, Chun, Song, Xun, Wang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697465/ https://www.ncbi.nlm.nih.gov/pubmed/36362861 http://dx.doi.org/10.3390/life12111706

Ejemplares similares

Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2
por: Ahmad, Sajjad, et al.
Publicado: (2021)

TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2
por: Wang, Yinfang, et al.
Publicado: (2021)

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
por: Wang, Qihui, et al.
Publicado: (2020)

Effect of polymorphism in Rhinolophus affinis ACE2 on entry of SARS-CoV-2 related bat coronaviruses
por: Li, Pei, et al.
Publicado: (2023)

SARS-CoV-2 Entry Factors: ACE2 and TMPRSS2 Are Expressed in Peri-Implantation Embryos and the Maternal–Fetal Interface
por: Chen, Wei, et al.
Publicado: (2020)

Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells
por: Yang, Hang, et al.
Publicado: (2022)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2
por: Chen, Xi, et al.
Publicado: (2022)

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020)

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
por: Qiao, Yuanyuan, et al.
Publicado: (2021)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract
por: Liu, Yichuan, et al.
Publicado: (2020)

Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
por: Hattori, Takanari, et al.
Publicado: (2022)

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
por: Han, Dong P., et al.
Publicado: (2006)

Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota
por: Edwinson, Adam, et al.
Publicado: (2021)

Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease
por: Lim, Key-Hwan, et al.
Publicado: (2020)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
por: Zamorano Cuervo, Natalia, et al.
Publicado: (2020)

The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19
por: Ahmad, Iqrar, et al.
Publicado: (2021)

Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
por: D’Onofrio, Nunzia, et al.
Publicado: (2021)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
por: Karthika, Thankamani, et al.
Publicado: (2021)

APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
por: Zhang, Hongsheng, et al.
Publicado: (2022)

Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
por: Liu, Jiamnin, et al.
Publicado: (2022)

Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
por: Burgueño, Juan F, et al.
Publicado: (2020)

Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry
por: Ren, Wenlin, et al.
Publicado: (2021)

Integrin αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2
por: Cai, Zeqiong, et al.
Publicado: (2023)

Identification of the SARS-CoV-2 Entry Receptor ACE2 as a Direct Target for Transcriptional Repression by Miz1
por: Yang, Jing, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry
por: Hou, Yuxuan, et al.
Publicado: (2010)

Potent Inhibition of Viral Entry and Replication of SARS-CoV by siRNAs Targeting the Genes Encoding the Cellular ACE2 Receptor or the Viral Nucleocapsid Protein
por: Yan, Xin, et al.
Publicado: (2007)

Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin
por: Ouyang, Yingshi, et al.
Publicado: (2021)

“Molecular Masks” for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry
por: Shukla, Satya Prakash, et al.
Publicado: (2021)

Palmitoylethanolamide (PEA) Inhibits SARS-CoV-2 Entry by Interacting with S Protein and ACE-2 Receptor
por: Fonnesu, Rossella, et al.
Publicado: (2022)

Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry
por: Yoshizato, Katsutoshi, et al.
Publicado: (2022)

Prime editor‐mediated functional reshaping of ACE2 prevents the entry of multiple human coronaviruses, including SARS‐CoV‐2 variants
por: Zhao, Wenwen, et al.
Publicado: (2023)

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
por: Zhang, Si, et al.
Publicado: (2020)

The impact of ACE2 and co‐factors on SARS‐CoV‐2 infection in colorectal cancer
por: Li, Shuwei, et al.
Publicado: (2022)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Co-expression of the SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in human ovaries: Identification of cell types and trends with age
por: Wu, Meng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3i9eq0cgegc4ta5hn0ds9nnqp6